GRIFOLS | GRF - Ebitda

Stock Price
9.09
Daily Change
-0.08 -0.92%
Monthly
-5.74%
Yearly
-0.74%
Q2 Forecast
8.71

GRIFOLS reported EUR347.45M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Alcon AG USD 795M 478M Mar/2026
Almirall EUR 114.07M 60.37M Dec/2025
Amadeus IT EUR 661.4M 83.5M Mar/2026
Amarin USD 12.54M 28.57M Jun/2025
argenx SE USD 404.12M 17.08M Dec/2025
AstraZeneca USD 5.67B 1.29B Mar/2026
Bayer EUR 4.45B 2.49B Mar/2026
Cie Automotive EUR 345.96M 35.96M Dec/2024
Demant DKK 2.76B 165M Dec/2025
Ence Energia y Celulosa EUR 12.8M 100K Dec/2025
Essilor EUR 3.09B 356M Dec/2024
Ferrovial EUR 542M 607M Dec/2025
Fresenius EUR 951M 283M Mar/2026
Fresenius Medical Care EUR 824M 250M Mar/2026
Genmab DKK 186M 291M Dec/2025
GlaxoSmithKline GBP 2.77B 1.65B Mar/2026
GRIFOLS EUR 347.45M 210K Dec/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Inditex EUR 2.97B 223M Dec/2025
Lakefront Biotherapeutics EUR -63.7M 624.2M Mar/2026
Merck EUR 1.44B 263M Dec/2025
Novartis USD 5.3B 530M Mar/2026
Philips EUR 567M 233M Mar/2026
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 3.31B 3.65B Mar/2026
Smith & Nephew USD 796M 139M Dec/2025
UCB EUR 1.6B 570M Dec/2025
Viscofan EUR 63.38M 8.37M Mar/2026